N
2.91
0.05 (1.93%)
| Penutupan Terdahulu | 2.85 |
| Jumlah Dagangan | 402,320 |
| Harga / Pendapatan (P/E Ke hadapan) | 34.25 |
| Harga / Jualan (P/S) | 28.19 |
| Harga / Buku (P/B) | 2.90 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -1.96 |
| Nisbah Semasa (MRQ) | 0.220 |
| Aliran Tunai Operasi (OCF TTM) | -10.45 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 3.23 M |
| Pulangan Atas Aset (ROA TTM) | -191.74% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | NRX Pharmaceuticals, Inc. | Bercampur | Menaik |
AISkor Stockmoo
-1.1
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -1.07 |
|
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 15.88% |
| % Dimiliki oleh Institusi | 13.34% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| B Group, Inc. | 30 Jun 2026 | 4,091,767 |
| Advisorshares Investments Llc | 30 Jun 2026 | 659,018 |
| Commonwealth Equity Services, Llc | 30 Jun 2026 | 454,418 |
| Bleakley Financial Group, Llc | 30 Jun 2026 | 117,216 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |